Welcome to the latest issue of BakerHostetler’s Life Sciences newsletter. In this edition, we explain how companies can prepare for increased congressional oversight, offer practical insights into key FDA and patent developments and share news and events from across the life sciences community. As 2026 draws to a close, our Life Sciences Industry team is here to help you understand emerging issues, pursue new opportunities and plan for the year ahead.
